Emcure IPO to stick hefty price tag on pharma firm, hand 26% return to Bain
Stay Home. Read Quality News
Advertisement
  • Home
  • Healthcare
  • Emcure IPO to stick hefty price tag on pharma firm, hand 26% return to Bain

Emcure IPO to stick hefty price tag on pharma firm, hand 26% return to Bain

By Ankit Agarwal

  • 20 Aug 2021
Premium
Emcure IPO to stick hefty price tag on pharma firm, hand 26% return to Bain

Pune-based Emcure Pharmaceuticals’ initial public offering (IPO) will make it the most expensive firm among peers and hand......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Become a Premium member
Already a member? Click here to log in.